NewslettersMammary Cell News Laminarin Suppresses PD-L1 Translation by Targeting YTHDF1 to Exert Antitumor Immunity in Triple-Negative Breast Cancer By mihika.mishra - October 15, 2026 0 9 Investigators demonstrated that laminarin, a biocompatible β-1,3-glucan extracted from brown algae, exerts significant antitumor immune effects against TNBC with no evident toxicity under the tested conditions. [Pharmacological Research] Full ArticleGraphical Abstract